EUGENIA CHEN: Open Payments
NPI 1285739730 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 8 payments from 5 companies in 2025. Trend: 2023 $885 · 2024 $599 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $112 |
| Ipsen Biopharmaceuticals, Inc | 1 | $110 |
| Regeneron Healthcare Solutions, Inc. | 2 | $107 |
| Gilead Sciences, Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $28 |
Products named: REZDIFFRA, IQIRVO, DUPIXENT, RINVOQ.
Industry payments across NH — which companies pay providers there.
